Showing results (151-160 of 547) with videos related to
Sort By:
Pageof 55
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidantsA Mansouri, C Demeilliers, S Amsellem, et al.Journal of Hepatology|February 1, 1996
Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in miceP Letteron, B Fromenty, B Terris, et al.Digestion|January 1, 1984
Amitriptyline-induced fulminant hepatitisG Danan, J Bernuau, X Moullot, et al.Polskie Archiwum Medycyny Wewnetrznej|February 1, 1993
[Evolution of cutaneous changes observed in cirrhosis patients before and after liver transplantation]H Bołdys, G P Pageaux, D Larrey, et al.Drug Safety|December 1, 1996
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver statusF Durand, G Jebrak, D Pessayre, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1981
Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in ratsM Le Dafniet, D Pessayre, L Le Quernec, et al.Journal of Clinical Gastroenterology|February 1, 1990
Heterogeneous hepatic venous pressures in patients with liver cancerS S Lee, A Koshy, A Hadengue, et al.Journal of Hepatology|January 1, 1985
Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranololP Calès, A Braillon, M I Jirón, et al.Lancet (London, England)|July 26, 1980
Propranolol--a medical treatment for portal hypertension?D Lebrec, O Nouel, M Corbic, et al.Journal of Hepatology|September 1, 1991
Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed ratsH C Lin, O Soubrane, S Cailmail, et al.Pageof 55